Global Engine Group Holding Limited

Sources: FY2025 20-F (FY2023–FY2025, audited); TipRanks and Simply Wall St (S&P Capital IQ-derived) for FY2021–FY2022, which originate from the F-1 audited statements; H1 FY2026 6-K (unaudited).

Analyst-computed metrics: EBITDA is defined here as operating income plus depreciation and amortization (including right-of-use amortization in FY2023–FY2024). Ratios are computed by the analyst.

Income statement

Cost of revenue for FY2021/FY2022 is derived as revenue minus gross profit. Tax for FY2021/FY2022 is derived as pre-tax income minus net income. The FY2023–FY2024 diluted EPS shown by some aggregators (HKD 0.15/0.14) assumes 18M diluted shares; the 20-F reports diluted EPS equal to basic.

Growth (%)

Revenue CAGR:

• FY2021–FY2025 (4-year): −2.6%

• FY2022–FY2025 (3-year): −25.0%

• FY2020–FY2025 (5-year, from HKD 10.0M): +18.2%. This figure flatters the trend because of the low FY2020 base.

Interim and trailing-twelve-month (TTM) view

TTM is computed by the analyst as FY2025 + H1 FY2026 − H1 FY2025. In USD, TTM revenue is about US$1.41M and the TTM net loss about US$1.29M, consistent with StockAnalysis.

1. Two-phase history. FY2020–FY2022 was a high-growth, high-margin period. Revenue rose five-fold to HKD 54.6M with net margins of 15–31%, driven by large project work, including CITD-group contracts that made up 19% of FY2023 revenue. From FY2023, margins compressed structurally. Gross margin fell from 39% to about 15% as the mix shifted toward pass-through subcontracted work, notably Intellino projects largely fulfilled by MDT Innovations (Labuan) and Nexsen.

2. FY2025 inflection. Revenue halved (−53.3%) as large contracts lapsed. Meanwhile, G&A rose 140% to HKD 10.75M. The 20-F MD&A and the ts2.tech summary attribute the increase to listed-company costs, legal and professional fees, and salaries. The year also carried HKD 0.65M of software amortization and a HKD 0.50M credit-loss provision. The result was the first operating loss (−HKD 7.1M). The net loss was cushioned by HKD 0.45M of interest income on IPO cash and a HKD 0.78M tax credit.

3. H1 FY2026 deterioration. Revenue fell a further 63% year on year. G&A doubled to HKD 7.6M, including a HKD 2.22M credit-loss provision. The allowance rose to HKD 2.82M against gross receivables of HKD 11.32M. The two largest debtors represented 79.1% and 11.2% of receivables. The interim gross margin improved to 20%, reflecting mix (related-party DataCube revenue), but the absolute gross profit pool (HKD 1.4M per half) covers less than 20% of G&A.

4. Share-based consultant costs ahead. The March 27, 2026 issuance of 2.4M Class A shares to third-party consultants under the 2025 Equity Incentive Plan will flow through H2 FY2026 G&A. This is non-cash but dilutive (+13.1% to the share count). The fair value recognised was not disclosed in the materials reviewed.

Balance sheet

Notes: FY2024–FY2025 figures are from the FY2025 20-F balance sheet: - Cash for FY2022–FY2023 comes from the cash-flow statement opening balances.

• Equity for FY2022–FY2023 is derived by rolling back retained earnings from the FY2024 balance. It is an analyst derivation that assumes no other equity movements.

• FY2021 receivables come from the F-1.

• There is no interest-bearing debt. The only liabilities to insiders are HKD 335 due to a director and HKD 2,709 due to BAO, a company related to the CEO.

• A FY2023 operating lease liability existed; it was fully amortised by FY2025.

Balance sheet commentary:

The IPO transformed the balance sheet. Equity rose from HKD 14.2M to HKD 63.3M, but by June 2025, 51% of assets were non-current and illiquid:

• the Corpotech minority stake (HKD 17.4M);

• capitalised software (HKD 12.3M);

• goodwill from Ace Vision (HKD 6.1M). Ace Vision's identifiable net assets were just HKD 0.11M, so 98% of the US$0.8M price was booked as goodwill.

Hard cash fell to HKD 18.0M (US$2.3M) by December 2025. Of that, HKD 15.4M was above the Hong Kong deposit-protection limit.

"Other payables" of HKD 5.1M at December 2025 represent collections held on behalf of a customer. These are a pass-through liability that will consume cash when paid.

Cash flow

FY2024 operating cash flow was HKD 1,810, effectively nil. FY2025 acquisitions and investments comprise HKD 17.47M for Corpotech and HKD 6.12M for Ace Vision (net of cash acquired). Cash paid for IPO costs across FY2023–FY2025 totals HKD 13.6M, about 19% of gross proceeds.

H1 FY2026 cash flow:

• Operating cash flow: −HKD 7.18M (−US$0.92M).

• Investing: −HKD 0.03M.

• Financing: nil.

• Net cash change: −HKD 7.21M.

Cash-runway analysis (analyst estimate): At the H1 FY2026 operating burn of about HKD 1.2M per month, December 2025 cash of HKD 18.0M implies roughly 15 months of runway, to about March 2027. This assumes no working-capital releases, no Corpotech dividends and no new financing. The February 2026 F-3 shelf is the obvious financing route, but a post-consolidation market value below US$10M would limit primary issuance under baby-shelf rules.

Ratios

Analyst computations from 20-F data. NOPAT uses the 16.5% Hong Kong headline tax rate. Net debt/EBITDA is not meaningful because the company holds net cash and has no debt. Interest coverage in FY2025 is not meaningful because EBIT was negative.

Ratio commentary: Returns collapsed from strongly positive (ROE about 20% in FY2024) to negative after the IPO. The cause was a larger equity base deployed into low- or non-yielding assets combined with losses.

The cash conversion cycle lengthened sharply. Payables were extinguished (HKD 12.8M paid down in FY2025, mostly to Nexsen and MDT for Intellino work) while receivables stayed high. This is the main reason FY2025 operating cash flow was −HKD 9.2M despite a smaller net loss. Rising credit-loss provisions in H1 FY2026 suggest receivable quality is deteriorating.

Management guidance and consensus

There is no quantitative management guidance and no sell-side consensus. Management's qualitative messaging, in the August and October 2026 releases, emphasises the "AI + Edge + Space" strategy, ASEAN expansion, and maintaining the Nasdaq listing.

Bull case (grounded in data)

1. Listing cured, value re-rated. If the post-consolidation price holds above US$1.00 for 10 consecutive business days before the second compliance period ends (about late October 2026), the delisting overhang lifts. With about 2.07M shares, P/B near 1x, and debt-free net cash of about US$2.3M (December 2025), downside to book could be limited if the burn is controlled.

2. The Space-to-AI proof of concept converts into a commercial pipeline. The July 2026 agreement gives GLE a defined design-and-operations role alongside SDEC. If the 180-day feasibility phase concludes positively in early 2027, follow-on ground-station and edge-datacenter work in Malaysia and Indonesia could rebuild revenue toward the FY2022–FY2024 band of HKD 45–55M. That band delivered net margins of 5–15%.

3. Hidden asset value in Corpotech. The 22.5% Tsing Yi data-center stake (HKD 17.4M carrying value) sits in a market growing 8.5–14.6% a year. A sale or revaluation could crystallise cash equal to a material share of today's market value.

Bear case (grounded in data)

1. Shrinking core plus fixed costs equals cash exhaustion. TTM revenue of HKD 11.0M and TTM G&A of HKD 14.6M mean losses exceed revenue. At the H1 FY2026 burn rate, cash lasts until about early 2027. A dilutive raise from a roughly US$7M market value appears likely.

2. Concentration and credit cliff. Customer and vendor concentration remains extreme (four customers made up 86.6% of H1 FY2026 revenue; one vendor 76.9% of purchases). One debtor holds 79.1% of receivables, and the allowance quadrupled to HKD 2.82M. Further write-offs, or goodwill and intangible impairments (HKD 17.5M at December 2025), could erode book value quickly.

3. Governance and dilution asymmetry. The founder holds about 87–89% of votes via Class B shares. 2.4M consultant shares were issued (13% dilution). The board approved the consolidation without shareholders under home-country practice. The CEO splits time with BAO Holding. Reverse splits in micro-caps frequently precede share-price decay and further issuance, and the post-split float of about 2M shares magnifies volatility.

Catalysts and monitorables (next 12 months)

Concluding analyst verdict

Global Engine Group is a founder-controlled Hong Kong ICT consultancy whose public-market history has been short and unfavourable. Before its September 2024 IPO, the business was small but profitable. It generated HKD 45–55M of annual revenue in FY2022–FY2024 with positive operating margins, built on a few relationship-driven contracts with VNET, Intellino and the CITD group.

Since listing, three things went wrong at once:

• revenue halved in FY2025 and fell another 63% in H1 FY2026;

• listing-related G&A more than doubled;

• most of the HKD 71.5M gross IPO raise went into illiquid assets rather than organic capability. These were the Ace Vision acquisition, almost entirely goodwill; a 22.5% minority data-center stake; and HKD 12.9M of undisclosed software.

Cash fell to US$2.3M by December 2025 against a half-year operating burn of about US$0.9M. Combined with extreme customer and vendor concentration, rising credit losses and persistent internal-control weaknesses, GLE's fundamental risk profile is that of a sub-scale micro-cap at a financing inflection.

The "AI + Edge + Space" partnership with Angkasa-X in Sarawak is strategically coherent with the founder's data-center background and is GLE's only visible growth vector. However, it carries no disclosed contract value or investment commitment. Its proof of concept is dated October 2027, well beyond the company's implied cash runway.

The 1-for-10 consolidation of October 8, 2026 is a necessary listing defence, not a value catalyst. History suggests elevated risk of post-split drift and dilutive issuance under the February 2026 shelf.

Verdict: High-risk, speculative, and governance-discounted. The equity is best viewed as an option on three outcomes: (i) successful Nasdaq compliance, (ii) monetisation of the Corpotech stake, and (iii) conversion of the Angkasa-X proof of concept into paid contracts. Investors should demand evidence on all three, together with stabilisation of core revenue above about HKD 10M per half-year and a credible cost reset, before attributing value beyond net tangible assets.